<DOC>
	<DOCNO>NCT02119039</DOCNO>
	<brief_summary>CACICOL20 ophthalmic solution base technology RGTAs ( ReGeneraTingAgents ) . It consist large biopolymers , imitate structure heparansulphate . The protect effect different biological tissue enhancement wound heal describe several study . Keratoconus relatively common disease , incidences range 1.3 25 per 100,000 per year across different population . Corneal collagen cross-linking represent treatment option patient , aim prevent progression disease via stabilization corneal microstructure . Corneal epithelial removal prior ultraviolet A/riboflavin cross-linking procedure significantly improve outcome intervention , due ameliorate distribution riboflavin . The aim present study investigate effect CACICOL20 corneal epithelial wound closure collagen cross-linking patient keratoconus . Results may lead improved management pain reduction patient corneal epithelial defect .</brief_summary>
	<brief_title>Effect CACICOL20 Corneal Epithelial Healing After Cross-linking Patients With Keratoconus</brief_title>
	<detailed_description />
	<mesh_term>Keratoconus</mesh_term>
	<criteria>Men woman age 18 year Presence keratoconus Scheduled corneal cross link No ophthalmic surgery 3 month precede study Participation clinical trial previous 3 week Topical use aminoglycosid antibiotic Use therapeutic refractive contact lenses surgery Known hypersensitivity component study medication heparinoids heparin Active ocular infection Presence abnormality prevent reliable measurement judge investigator Pregnancy , plan pregnancy lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Cross-linking</keyword>
	<keyword>RGTA OTR4120 ( CACICOL20 )</keyword>
</DOC>